FindTrial
Sign In

A clinical trial to study the effect of 3 drugs, dexmedetomidine, fentanyl, ketamine in addition to lignocaine nebulization for anesthetizing airway in patients undergoing awake fibreoptic intubation.

Comparison of dexmedetomidine, fentanyl, ketamine nebulization as an adjuvant to lignocaine for awake fibreoptic intubation.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/049238
Enrollment
84
Registered
2023-01-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: 4% lignocaine with Dexmedetomidine : 4% Lignocaine-Dose-160mg, Route-Inhalational route,Duration-20min, Frequency-Single dose. Dexmedetomidine- Dose-1 mcg/kg, Route-Inhalational route,

Sponsors

Yenepoya medical college hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients under the category of ASA I/II(American Society of Anaesthesiologist).

Exclusion criteria

Exclusion criteria: 1.Previous Airway surgery 2.Anticipated difficult airway 3.Nasal Trauma 4.Allergy to Local Anesthetics

Design outcomes

Primary

MeasureTime frame
1.To determine the cough score. 2.To determine the rate of glottic closure during bronchoscopy and intubation.Timepoint: the time from the starting of intubation till the tube reaches the trachea (about 30sec)—

Secondary

MeasureTime frame
1.To evaluate sedation score. 2.To observe for any other adverse effects.Timepoint: the time from the intubation till securing the airway(about 60 sec)—

Countries

India

Contacts

Public ContactDrSmita Musti

Yenepoya Medical College, Mangalore

smitamusti@gmail.com9886125842

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026